Melatonin

Encyclopedia of Dietary Supplements

Volumn , Issue , 2004, Pages 457-466

  Wurtman, Richard J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85059714087     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1081/E-EDS-120022908     Document Type: Chapter

References (48)

1. McCord, C.P.; Allen, F.P. Evidences associating pineal gland function with alterations in pigmentation. J. Exp. Zool. 1917, 23, 207–224.
2. Lerner, A.B.; Case, J.D.; Takahashi, Y.; Lee, T.H.; Mori, W. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J. Am. Chem. Soc. 1958, 80, 2587.
3. Kitay, J.I.; Altschule, M.D. Effects of pineal extract administration on ovary weight in rats. Endocrinology 1954, 55, 782–784.
4. Fiske, V.M.; Bryant, K.; Putnam, J. Effect of light on the weight of pineal in the rat. J. Endocrinol. 1960, 66, 489–491.
5. Ariens-Kappers, J. Innervation of the epiphysis cerebri in the albino rat. Anat. Rec. 1960, 136, 220–221.
6. Wurtman, R.J.; Roth, W.; Altschule, M.D.; Wurtman, J.J. Interactions of the pineal and exposure to continuous light on organ weights of female rats. Acta Endocrinol. 1961, 36, 617–624.
7. Wurtman, R.J.; Axelrod, J.; Chu, E.W. Melatonin, a pineal substance: effect on the rat ovary. Science 1963, 141 (3577), 277–278.
8. Wurtman, R.J.; Axelrod, J.; Fischer, J.E. Melatonin synthesis in the pineal gland: effect of light mediated by the sympathetic nervous system. Science 1964, 143 (3612), 1328–1330.
9. Axelrod, J.; Shein, H.M.; Wurtman, R.J. Stimulation of C14-melatonin synthesis from C14-tryptophan by noradrenaline in rat pineal in organ culture. Proc. Natl. Acad. Sci. U.S.A. 1969, 62, 544–549.
10. Wurtman, R.J.; Shein, H.M.; Larin, F. Mediation by b-adrenergic receptors of effect of norepinephrine on pineal synthesis of [14C]serotonin and [14C]melatonin. J. Neurochem. 1971, 18, 1683–1687.
11. Klein, D.C.; Moore, R.Y. Pineal N-acetyltransferase and hydroxyindole-O-methyltransferase: control by a retinohypothalamic tract and the suprachiasmatic nucleus. Brain Res. 1979, 174, 245–262.
12. Lynch, H.J.; Wurtman, R.J.; Moskowitz, M.A.; Archer, M.C.; Ho, M.H. Daily rhythm in human urinary melatonin. Science 1975, 187, 169–171.
13. Wurtman, R.J.; Axelrod, J. The pineal gland. Sci. Am. 1965, 213 (1), 50–60.
14. Skene, D.J.; Vivien-Roels, B.; Sparks, D.L.; Hunsaker, J.C.; Pevey, P.; Ravid, D.; Swaab, D.F. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effects of age and Alzheimer’s disease. Brain Res. 1990, 528 (1), 170–174.
15. Tricoire, H.; Locatelli, A.; Chemineau, P.; Malpaux, B. Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology 2002, 143 (1), 84–90.
16. Kopin, I.J.; Pare, C.M.; Axelrod, J.; Weissbach, H. 6-Hydroxylation, the major metabolic pathway for melatonin. Biochim. Biophys. Acta 1960, 40, 377–378.
17. Witt-Enderby, P.A.; Bennett, J.; Jarzynka, M.J.; Firestine, S.; Melan, M.A. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci. 2003, 72, 2183–2198.
18. Hattori, A.; Migitaka, H.; Iigo, M.; Itoh, M.; Yamamoto, K.; Ohtani-Kaneko, R.; Hara, M.; Suzuki, T.; Reiter, R.J. Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem. Mol. Biol. Int. 1995, 35 (3), 627–634.
19. Van Tassel, D.L.; Roberts, N.; Lewy, A.; O’Neill, S.D. Melatonin in plant organs. J. Pineal Res. 2001, 31, 8–15.
20. Mayeda, A.; Mannon, S.; Hofstetter, J.; Adkins, M.; Baker, R.; Hu, K.; Nurnberger, J. Jr. Effects of indirect light and propranolol on melatonin levels in normal human subjects. Psychiatry Res. 1998, 81, 9–17.
21. Garde, E.; Micic, S.; Knudsen, K.; Angelo, H.R.; Wulf, H.C. 8-Methoxypsoralen increases daytime plasma melatonin levels in humans through inhibition of metabolism. Photochem. Photobiol. 1994, 60 (5), 475–480.
22. Ekman, A.C.; Leppauluoto, J.; Huttunen, P.; Aranko, K.; Vakkuri, O. Ethanol inhibits melatonin secretion in healthy volunteers in a dosedependent randomized double blind cross-over study. J. Clin. Endocrinol. Metab. 1993, 77 (3), 780–783.
23. Lewy, A.J.; Wehr, T.A.; Goodwin, F.K.; Newsome, D.A.; Markey, S.P. Light suppresses melatonin secretion in humans. Science 1980, 210, 1267–1269.
24. Kennaway, D.J.; Stamp, G.E.; Goble, F.C. Development of melatonin production in infants and the impact of prematurity. J. Clin. Endocrinol. Metab. 1992, 75, 367–369.
25. Waldhauser, F.; Lynch, H.J.; Wurtman, R.J. Melatonin in human body fluids: clinical significance. In The Pineal Gland. Comprehensive Endocrinology; Reiter, R.J., Ed.; Raven Press: New York, 1984; 345–370.
26. Waldhauser, F.; Lieberman, H.R.; Lynch, H.J.; Waldhauser, M.; Herkner, K.; Frisch, H.; Vierhapper, H.; Waldhausl, W.; Schemper, M.; Wurtman, R.J.; Crowley, W.F. A pharmacological dose of melatonin increases PRL levels in males without altering those of GH, LH, FSH, TSH, testosterone or cortisol. Neuroendocrinology 1987, 46, 125–130.
27. Dollins, A.B.; Lynch, H.J.; Wurtman, R.J.; Deng, M.H.; Kischka, K.U.; Gleason, R.E.; Lieberman, H.R. Effect of pharmacological daytime doses of melatonin on human mood and performance. Psychopharmacology 1993, 112, 490–496.
28. Dollins, A.B.; Zhdanova, I.V.; Wurtman, R.J.; Lynch, H.J.; Deng, M.H. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 1824–1828.
29. Di, W.-L.; Kadva, A.; Johnston, A.; Silman, R. Variable bioavailability of oral melatonin. N. Engl. J. Med. 1997, 336 (14), 1028–1029.
30. Deacon, S.; Arendt, J. Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans. Brain Res. 1995, 688, 77–85.
31. Duell, P.B.; Wheaton, D.L.; Shultz, A.; Nguyen, H. Inhibition of LDL oxidation by melatonin requires supraphysiologic concentrations. Clin. Chem. 1998, 44, 9.
32. Pappolla, M.; Bozner, P.; Soto, C.; Shao, H.; Robakis, N.K.; Zagorski, M.; Frangione, B.; Ghiso, J. Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J. Biol. Chem. 1998, 273, 7185–7188.
33. Lewy, A.J.; Ahmed, S.; Latham Jackson, J.M.; Sack, R.L. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol. Int. 1992, 9 (3), 380–392.
34. Zhdanova, I.V.; Wurtman, R.J. Efficacy of melatonin as a sleep-promoting agent. J. Biol. Rhythms 1997, 12 (6), 644–650.
35. Brzezinski, A.; Vangel, M.G.; Wurtman, R.J.; Norrie, G.; Zhdanova, I.; Ben-Shushan, A.; Ford, I. Effect of exogenous melatonin on sleep: A meta-analysis. Sleep Med. Revs. 2005, 9 (1), doi: 10.1016/j.smrv.2004.06.004.
36. James, S.P.; Sack, D.A.; Rosenthal, N.E.; Mendelson, W.B. Melatonin administration in insomnia. Neuropsychopharmacology 1990, 3 (1), 19–23.
37. Waldhauser, F.; Saletu, B.; Trinchard-Lugan, I. Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacology 1990, 100, 222–226.
38. Dahlitz, M.; Alvarez, B.; Vignau, J.; English, J.; Arendt, J.; Parkes, J.D. Delayed sleep phase syndrome response to melatonin. Lancet 1991, 337, 1121–1124.
39. Haimov, I.; Lavie, P.; Laudon, M.; Herer, P.; Vigder, C.; Zisapel, N. Melatonin replacement therapy of elderly insomniacs. Sleep 1995, 18 (7), 598–603.
40. Garfinkel, D.; Laudon, M.; Nof, D.; Zisapel, N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995, 346, 541–544.
41. Attenburrow, M.E.; Cowen, P.J.; Sharpley, A.L. Low dose melatonin improves sleep in healthy middle-aged subjects. Psychopharmacology 1996, 126, 179–181.
42. Shamir, E.; Laudon, M.; Barak, Y.; Anis, Y.; Rotenburg, V.; Elizur, A.; Zisapel, N. Melatonin improves sleep quality of patients with chronic schizophrenia. J. Clin. Psychiatry 2000, 61, 373–377.
43. Singer, S.; Tractenberg, R.E.; Kaye, J.; Schafer, K.; Gamst, A.; Grundman, M.; Thomas, R.; Thal, L.J. A multicenter placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep 2003, 26, 1–7.
44. Zhdanova, I.V.; Wurtman, R.J.; Regan, M.M.; Taylor, J.A.; Shi, J.P.; Leclair, O.U. Melatonin treatment for age-related insomnia. J. Clin. Endocrinol. Metab. 2001, 86 (10), 4727–4730.
45. Arendt, J.; Aldhous, M.; Wright, J. Synchronisation of a disturbed sleep–wake cycle in a blind man by melatonin treatment. Lancet 1988, i, 772–777.
46. Arendt, J. Jet-lag and shift work: (2). Therapeutic use of melatonin. J. R. Soc. Med. 1999, 92 (8), 402–405.
47. Rodriguez, C.; Mayo, J.C.; Sainz, R.M.; Antolin, I.; Herrera, F.; Martin, V.; Reiter, R.J. Regulation of antioxidant enzymes: a significant role for melatonin. J. Pineal Res. 2004, 36, 1–9.
48. Bonn, D. Melatonin’s multifarious marvels: miracle or myth? Lancet 1996, 347, 184.